Canine health company Hemopet received its fourth patent for the company's nutrigenomics portfolio.
Hemopet says its business strategy calls for launching nutrigenomic petfood supplements in 2012, formulas which are currently being tested in Europe.
“Our intellectual property protects and confirms Hemopet as a leader in nutrigenomic petfoods. It validates our being at the forefront of petfood issues and further builds on our philosophy of individualized care for pets,” said Dr. Jean Dodds, president.
